Health Affairs: Smoothing Part D out-of-pocket costs under the Inflation Reduction Act
Following the passage of the Inflation Reduction Act of 2022, which included several historic Medicare reforms, media coverage has often focused on the $2,000 annual cap on out-of-pocket prescription costs. But one key reform has been missing from the headlines: smoothing. This article, published in Health Affairs Forefront, discusses the importance of smoothing—the option to … Continued